The following industries match your search criteria:
Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
»
»|
Click here
to sort results by relevance.
Click on heading titles to sort results by different field.
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Analysis of Zydus Cadila’s corporate history, corporate relationships, biosimilars development pipeline, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.
Published By Datamonitor
|
06 Jul 2012 |
$3800
|
Report
|
Datamonitor’s report provides an overview of developments regarding drug regulation, healthcare reform, and intellectual property issues in the US.
Published By Datamonitor
|
15 Nov 2011 |
$1900
|
Report
|
Overview of the US pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
27 Sep 2010 |
$11400
|
Report
|
Overview of the UK pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
14 Jun 2010 |
$11400
|
Report
|
This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.
Published By Datamonitor
|
29 Jun 2011 |
$1900
|
Report
|
Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.
Published By Datamonitor
|
29 Jun 2011 |
$1900
|
Report
|
Analysis of Teva’s corporate history, corporate relationships, biosimilars development pipeline, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.
Published By Datamonitor
|
06 Jul 2012 |
$3800
|
Report
|
Analysis of Teva's corporate strategy and sales performance in 2010 to 2016.
Published By Datamonitor
|
04 May 2012 |
$5700
|
Report
|
Analysis of Takeda's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016
Published By Datamonitor
|
14 Dec 2011 |
$5700
|
Report
|
Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.
Published By Datamonitor
|
23 Aug 2012 |
$3800
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.